Transporter-mediated drug-drug interactions

被引：0
|
作者：
Shitara, Yoshihisa [1 ]
机构：
[1] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba, Japan
来源：
DRUG METABOLISM REVIEWS | 2006年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：12 / 13
页数：2
相关论文
共 50 条
  • [41] Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling
    Ball, Kathryn
    Jamier, Tanguy
    Parmentier, Yannick
    Denizot, Claire
    Mallier, Agnes
    Chenel, Marylore
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 : 122 - 132
  • [42] PREDICTION OF DRUG-DRUG INTERACTIONS MEDIATED BY INTESTINAL TRANSPORTER
    Tachibana, Tatsuhiko
    Kato, Motohiro
    Mitsui, Tetsuya
    Sugiyama, Yuichi
    DRUG METABOLISM REVIEWS, 2007, 39 : 123 - 124
  • [43] Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions
    Chu, Xiaoyan
    Chan, Grace Hoyee
    Evers, Raymond
    JOURNAL OF PHARMACEUTICAL SCIENCES, 2017, 106 (09) : 2357 - 2367
  • [44] TERIFLUNOMIDE: POTENTIAL FOR TRANSPORTER MEDIATED DRUG-DRUG INTERACTIONS
    Weitz, D.
    Schmider, W.
    Menguy-Vacheron, F.
    Clot, P.
    Hermabessiere, S.
    Jiang, J.
    Su, Y.
    Thuillier, V.
    Turpault, S.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2013, 93 : S112 - S113
  • [45] Transporter-mediated drug-herb and drug-food interactions
    Morris, Marilyn E.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2010, 240
  • [46] PET-CT imaging for assessment of transporter-mediated drug-drug interactions at the blood-brain-barrier
    Lappchen, Tilman
    Vlaming, Maria L. H.
    Jansen, Harm T.
    van der Hoorn, Jose W. A.
    Kivits, Suzanne
    van Driel, Andy
    Custers, Erica
    Lub, Johan
    Sio, Charles F.
    Steinbach, Oliver C.
    DeGroot, Jeroen
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2011, 54 : S84 - S84
  • [47] Response to the Comment on the Article "Physiologically Based Modeling of Pravastatin Transporter-Mediated Hepatobiliary Disposition and Drug-Drug Interactions"
    Varma, Manthena V. S.
    Lai, Yurong
    Feng, Bo
    Litchfield, John
    Goosen, Theunis C.
    Bergman, Arthur
    PHARMACEUTICAL RESEARCH, 2013, 30 (06) : 1469 - 1470
  • [48] In Vitro Evaluation of Hepatic Transporter-Mediated Clinical Drug-Drug Interactions: Hepatocyte Model Optimization and Retrospective Investigation
    Bi, Yi-an
    Kimoto, Emi
    Sevidal, Samantha
    Jones, Hannah M.
    Barton, Hugh A.
    Kempshall, Sarah
    Whalen, Kevin M.
    Zhang, Hui
    Ji, Chengjie
    Fenner, Katherine S.
    El-Kattan, Ayman F.
    Lai, Yurong
    DRUG METABOLISM AND DISPOSITION, 2012, 40 (06) : 1085 - 1092
  • [49] A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter-Mediated Drug-Drug Interactions
    Gessner, Arne
    Mueller, Fabian
    Wenisch, Pia
    Heinrich, Markus R. R.
    Koenig, Joerg
    Stopfer, Peter
    Fromm, Martin F. F.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (05) : 1058 - 1072
  • [50] Prediction of Clinical Transporter-Mediated Drug-Drug Interactions via Comeasurement of Pitavastatin and Eltrombopag in Human Hepatocyte Models
    Carter, Simon J.
    Chouhan, Bhavik
    Sharma, Pradeep
    Chappell, Michael J.
    CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2020, 9 (04): : 211 - 221
12345